Correlates of Antithrombin, Protein C, Protein S, and TFPI in a Healthy Elderly Cohort

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Thrombosis and Haemostasis

• Publication date

  1998-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/s-0037-1615152PMID 9684799
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue factor pathway inhibitor.

  1999cited by this paper
• Regulation of plasminogen gene expression by interleukin-6.

  1997cited by this paper
• Tissue factor pathway inhibitor blocks cellular effects of endotoxin by binding to endotoxin and interfering with transfer to CD14.

  1997cited by this paper
• Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects.

  1997cited by this paper
• Antithrombin and atherosclerosis in the Rotterdam Study.

  1996cited by this paper
• Association of Fibrinogen and Coagulation Factors Vll and VIII with Cardiovascular Risk Factors in the Elderly The Cardiovascular Health Study

  1996cited by this paper
• The association of plasma lipids and vitamin K-dependent coagulation factors.

  1996cited by this paper
• Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease.

  1996influential reference
• Antithrombin III and fibrinogen as predictors of cardiac events in patients with angina pectoris.

  1996cited by this paper
• Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators.

  1996cited by this paper
• Tissue Factor Pathway Inhibitor

  1995cited by this paper
• Activated protein C resistance and inherited thrombosis.

  1995cited by this paper
• Laboratory methods and quality assurance in the Cardiovascular Health Study.

  1995cited by this paper
• Antithrombin III: Associations with Age, Race, Sex and Cardiovascular Disease Risk Factors

  1994cited by this paper
• Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.

  1993cited by this paper
• Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study.

  1993cited by this paper
• The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.

  1992cited by this paper
• Association of coagulation factors and inhibitors with carotid artery atherosclerosis. Early results of the Atherosclerosis Risk in Communities (ARIC) Study.

  1992cited by this paper
• The binding and regulation of protein S by neutrophils

  1991cited by this paper
• The Cardiovascular Health Study: design and rationale.

  1991influential reference
• Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group.

  1991cited by this paper
• Studies on the measurement of protein S in plasma.

  1991cited by this paper
• Correlations between t-PA and PAI-1 antigen and activity and t-PA/PAI-1 complexes in plasma of control subjects and of patients with increased t-PA or PAI-1 levels.

  1990cited by this paper
• Measurement of plasminogen activator inhibitor 1 (PAI-1) in plasma with various monoclonal antibody-based enzyme-linked immunosorbent assays.

  1990cited by this paper
• Laboratory Diagnosis of Protein C Deficiency

  1990cited by this paper
• Protein C Inhibitor: Structure and Function

  1989cited by this paper
• Purification and characterization of the lipoprotein-associated coagulation inhibitor from human plasma.

  1989cited by this paper
• Congenital antithrombin III deficiency. Incidence and clinical features.

  1989cited by this paper
• A monoclonal-antibody-based radioimmunoassay for measurement of protein C in plasma.

  1988cited by this paper
• Increased protein C and fibrinopeptide A concentration in patients with angina.

  1988cited by this paper
• Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay.

  1988cited by this paper
• INHIBITOR OF THE FACTOR VIIA-TISSUE FACTOR COMPLEX IS REDUCED IN PATIENTS WITH DISSEMINATED INTRAVASCULAR COAGULATION BUT NOT IN PATIENTS WITH SEVERE HEPATOCELLULAR DISEASE

  1987cited by this paper
• Fibrinolytic Response and Fibrin Fragment D-Dimer Levels in Patients with Deep Vein Thrombosis

  1987cited by this paper
• An Enzyme-Linked Immunosorbent Assay (ELISA) for the Measurement of Plasmin-α2-Antiplasmin Complex in Human Plasma - Application to the Detection of In Vivo Activation of the Fibrinolytic System

  1986cited by this paper
• Assay of Human Tissue-Type Plasminogen Activator (t-PA) with an Enzyme-Linked Immunosorbent Assay (ELISA) Based on Three Murine Monoclonal Antibodies to t-PA

  1985cited by this paper
• Hereditary protein S deficiency.

  1985cited by this paper
• High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein.

  1981cited by this paper
• Chemistry of the hemostatic mechanism and its relationship to the action of heparin.

  1977cited by this paper
• The Electrocardiogram in Population Studies: A Classification System

  1960cited by this paper

• Estrogen and obesity synergistically suppress protein S via HIF1α, enhancing thrombosis potential

  2025cites this paper
• Tissue factor pathway inhibitor levels and atherothrombotic events in patients with chronic kidney disease or diabetes

  2025cites this paper
• Antithrombotic therapy in the elderly and senile age: the consensus opinion of experts of the Russian Association of Gerontologists and Geriatricians and the National Society of Preventive Cardiology

  2021cites this paper
• Hemostatic factor levels and cognitive decline in older adults: The Cardiovascular Health Study

  2021cites this paper
• Dual Effects of Large Spleen Volume After Splenectomy for the Patients With Chronic Liver Disease

  2019cites this paper
• Correlation of the tamoxifen use with the increased risk of deep vein thrombosis and pulmonary embolism in elderly women with breast cancer

  2018cites this paper
• The impact of TFPI on coronary atherosclerotic burden.

  2018cites this paper
• Relationship between plasma protein S levels and apolipoprotein C-II in Japanese middle-aged obese women and young nonobese women

  2018cites this paper
• Associations of activated coagulation factor VII and factor VIIa‐antithrombin levels with genome‐wide polymorphisms and cardiovascular disease risk

  2018cites this paper
• Hematological Changes with Aging

  2017cites this paper
• Association study to evaluate TFPI gene in CAD in Han Chinese

  2017cites this paper
• D-Dimer in African Americans: Whole Genome Sequence Analysis and Relationship to Cardiovascular Disease Risk in the Jackson Heart Study

  2017cites this paper
• The role of the tissue factor and its inhibitor in the development of subclinical atherosclerosis in people living with HIV

  2017cites this paper
• Антитромботическая терапия в первичной профилактике инсульта

  2017cites this paper
• Identification of Genetic Variants Linking Protein C and Lipoprotein Metabolism: The ARIC Study (Atherosclerosis Risk in Communities)

  2017cites this paper
• Endothelium-Dependent Hemostatic Factors in Women with Previous Gestational

  2016cites this paper
• Single nucleotide polymorphisms in an intergenic chromosome 2q region associated with tissue factor pathway inhibitor plasma levels and venous thromboembolism

  2016cites this paper
• The Levels of PAI-1, Urokinase uPA, Thrombomodulin and TFPI in Essential Thrombocythemia

  2015cites this paper
• Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

  2015cites this paper
• Dysfunkcja śródbłonka i rozwój subklinicznej miażdżycy u pacjentów zakażonych HIV z koinfekcją HCV

  2015cites this paper
• Changes in the levels of endothelium-derived coagulation parameters in nonalcoholic fatty liver disease

  2014cites this paper
• Aging Hemostasis: Changes to Laboratory Markers of Hemostasis As We Age—A Narrative Review

  2014cites this paper
• Hematologic Changes with Aging

  2014cites this paper
• Ocena zmian okołooperacyjnych poziomu czynnika tkankowego (TF) i jego inhibitora (TFPI) u chorych z tętniakiem aorty brzusznej leczonych metodą klasyczną i wewnątrznaczyniową

  2014cites this paper
• The role of tissue factor pathway inhibitor in atherosclerosis and arterial thrombosis.

  2013cites this paper
• Low cut-off values increase diagnostic performance of protein S assays

  2010cites this paper
• Aging Induces Endothelial Dysfunction While Sparing Arterial Thrombosis

  2010cites this paper
• Biological Variation in Tests of Hemostasis

  2009cites this paper
• Human plasma kallikrein-kinin system: physiological and biochemical parameters.

  2009cites this paper
• Thrombin increases inflammatory cytokine and angiogenic growth factor secretion in human adipose cells in vitro

  2009cites this paper
• Biological Variation in Tests of Hemostasis 2

  2009cites this paper
• Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism.

  2009cites this paper
• Tissue factor pathway inhibitor, vascular risk factors and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis.

  2009cites this paper
• Biological Variation in Tests of Hemostasis

  2008cites this paper
• PROC, PROCR and PROS1 polymorphisms, plasma anticoagulant phenotypes, and risk of cardiovascular disease and mortality in older adults: the Cardiovascular Health Study

  2008cites this paper
• Intra-arterial thrombolysis for acute stroke in patients 80 and older: a comparison of results in patients younger than 80 years.

  2007cites this paper
• Intra-Arterial Thrombolysis for Acute Stroke in Patients 80 and Older : A Comparison of Results in Patients Younger than 80 Years

  2006cites this paper
• Demonstration of plasminogen-like protein in amphioxus with implications for the origin of vertebrate liver

  2006cites this paper
• Tissue factor pathway inhibitor: structure, biology and involvement in disease

  2006cites this paper
• Hemostasis and aging.

  2006cites this paper
• Comment expliquer l’augmentation des thromboses chez le sujet âgé ?

  2005cites this paper
• Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.

  2005cites this paper
• [What explains the increased rate of thromboses among the elderly? Pathophysiological data].

  2005cites this paper
• A Locus on Chromosome 2 Influences Levels of Tissue Factor Pathway Inhibitor: Results From the GAIT study

  2005cites this paper
• Diagnostic du sepsis, du sepsis sévère et du choc septique : Sepsis sévère et choc septique

  2004cites this paper
• Subclinical cardiovascular disease in older adults: insights from the Cardiovascular Health Study.

  2004cites this paper
• [Diagnosis of sepsis, severe sepsis and septic shock].

  2004cites this paper
• Potential of free-form TFPI and PAI-1 to be useful markers of early atherosclerosis in a Japanese general population (the Suita Study): association with the intimal-medial thickness of carotid arteries.

  2004cites this paper
• Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial

  2003cites this paper
• Thrombin, inflammation, and cardiovascular disease: an epidemiologic perspective.

  2003cites this paper
• Venous Thromboembolism in Medical Patients-The Scope of the Problem

  2003cites this paper
• Local tissue factor pathway inhibitor release in the human forearm

  2003cites this paper
• Aging and Thrombosis

  2002cites this paper
• [Acute coronary syndrome--better risk stratification by determination of inflammatory parameters?].

  2002cites this paper
• Antithrombotic agents in the treatment of severe sepsis

  2002cites this paper
• Akutes Koronarsyndrom – bessere Risikostratifizierung durch Bestimmung von Entzündungsparametern?

  2002cites this paper
• Localization of Regulatory Elements Mediating Constitutive and Cytokine-stimulated Plasminogen Gene Expression*

  2002cites this paper
• Hemostatic and inflammatory markers as risk factors for coronary disease in the elderly.

  2002cites this paper
• Diabetes and Atherothrombotic Disease: Linked through Inflammation?

  2002cites this paper
• Antithrombotic Agents in the Management of Sepsis.

  2002cites this paper
• Tissue factor pathway inhibitor (TFPI) in patients with occlusive arterial diseases in consideration with risk factors and conservative treatment of the disease

  2001cites this paper
• Structure and Biology of Tissue Factor Pathway Inhibitor

  2001cites this paper
• Activated protein C versus protein C in severe sepsis

  2001cites this paper
• Post‐menopausal hormone therapy and concentrations of protein C and antithrombin in elderly women

  2001cites this paper
• [Venous thromboembolic pathology. New acquired risk factors or new data on acquired risk factors].

  2001cites this paper
• Genetic Regulation of Plasma Levels of Vitamin K-dependent Proteins Involved in Hemostasis

  2001cites this paper
• Risk Factors in Venous Thromboembolism

  2001cites this paper
• BASES GENÉTICAS DE LOS COMPONENTES DE LA HEMOSTASIA Y DEL RIESGO DE ENFERMEDAD TROMBOEMBÓLICA

  2001cites this paper
• Genetic regulation of plasma levels of vitamin K-dependent proteins involved in hematostatis: results from the GAIT Project. Genetic Analysis of Idiopathic Thrombophilia.

  2001cites this paper
• A new sensitive chromogenic substrate assay of tissue factor pathway inhibitor type 1.

  2000cites this paper
• Fibrinolytic/hemostatic variables in arterial hypertension: response to treatment with irbesartan or atenolol.

  2000cites this paper
• Age-dependency in molecular markers of haemostasis, fibrinolysis and in soluble adhesion molecules

  2000cites this paper
• Thromboembolism and thromboprophylaxis in high risk surgery: facts and assumptions--a topic for emotions?

  2000cites this paper
• Inflammation markers and coronary heart disease.

  1999cites this paper
• Mechanisms of Hypercoagulability

  1999cites this paper
• Tissue factor pathway inhibitor ( TFPI ) in patients with occlusive arterial diseases in consideration with risk factors and conservative treatment of the disease Inhibitor

  year unknowncites this paper